The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
Background: Warfarin is the most commonly used drug in the management of thromboembolic disease. However, there is a huge variability in the management of warfarin affecting the international normalized ratio (INR). Many genetic-association studies have reported on European and Asian populations whi...
Main Author: | Cindi, Zinhle |
---|---|
Other Authors: | Dandara, Collet |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/29461 |
Similar Items
-
VKORC1 variants as significant predictors of warfarin dose in Emiratis
by: Al-Mahayri ZN, et al.
Published: (2019-04-01) -
A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats☆
by: Michael H. Kohn, et al.
Published: (2008-11-01) -
Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017-03-01) -
Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction
by: Marianne K. Kringen, et al.
Published: (2011-01-01) -
VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People
by: Lindsay M. Henderson, et al.
Published: (2019-05-01)